Gelest, Inc. has received U.S. EPA approval to use new and improved manufacturing processes for its BIOSAFE antimicrobials, which will significantly expand its production capacities, states a Gelest, Inc. press release.
Gelest and its suppliers teamed up to overcome material supply shortages to ensure Gelest can meet the surging demand for BIOSAFE from all of its customers, especially healthcare professionals. These antimicrobials are found in a wide range of EPA-approved applications, such as Careismatic Certainty SmartBoost Laundry Additive for healthcare uniforms. They are used to preserve the treated articles by preventing the growth of stain and odor causing bacteria, fungi, mold and mildew.
Due to the COVID-19 pandemic, the demand for sanitizers, disinfectants, and antimicrobials has skyrocketed. Suppliers not only have to find ways to expand production capacities but must also overcome raw material supply shortages due to the disruption of the global supply chain.
“At Gelest, we continue to find new ways to ensure availability of our BIOSAFE antimicrobials to meet our customers’ needs,” said Shiming Wo, Gelest Vice President and General Manager Life Science. “For example, we invested in developing new processes with shorter cycle time, and successfully obtained EPA approval for the implementation of these advancements in the manufacturing of our BIOSAFE products.”
